A ground breaking new trial exploring treatment for Inflammatory Bowel disease is about to get underway at McMaster University.
For the first time, researchers will be studying the impact of fecal transplants in children who have the disease.
This means medical staff will transfer material from a healthy donor into a patient’s gastrointestinal tract through an enema, endoscope, or catheter.
McMaster researchers previously studied adults with IBD and found that fecal transplants can improve symptoms of ulcerative colitis.
According to Principal investigator, Dr. Nikhil Pai, 1 in 150 Canadians have the disease.
Ontario in particular, Pai adds, has one of the highest rates of childhood onset IBD in the entire world.
The PediFETCh study will help determine if these transplants can be an effective treatment for children who cannot control their disease with medications, who want to avoid increasing their dosage or being subject to surgery.